Regulatory mechanism of osteoclast activation

Journal of Electron Microscopy

Volumn 52, Issue 6, 2003, Pages 527-533

  Nakamura, Ichiro ^a,b   Rodan, Gideon A ^c   Duong, Le T ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yugawara Kosei Nenkin Hospital   (Japan)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

V 3 integrin; c Cbl; c Src; Osteoclast; p130Cas; Pyk2

Indexed keywords

VITRONECTIN RECEPTOR;

ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; OSTEOCLAST; OSTEOLYSIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BONE RESORPTION; CELLS, CULTURED; GENE EXPRESSION REGULATION; INTEGRIN ALPHAVBETA3; MICE; OSTEOCLASTS; SIGNAL TRANSDUCTION;

ANIMALIA;

ABSTRACTING; BONE; PROTEINS;

BONE RESORPTION; C-CBL; C-SRC; DIFFERENTIATED CELLS; INTEGRINS; OSTEOCLAST; P130CAS; PYK2; REGULATORY MECHANISM; ΑVΒ3INTEGRIN;

CHEMICAL ACTIVATION;

EID: 0347724014     PISSN: 00220744     EISSN: None     Source Type: Journal    
DOI: 10.1093/jmicro/52.6.527     Document Type: Review

References (55)

1. Suda T, Nakamura I, Jimi E, and Takahashi N (1997) Regulation of osteoclast function. J. Bone Miner. Res. 12: 869-879.
2. 3 in osteoclast differentiation and function. In: Methods in Enzymology, Vitamins and Coenzymes, vol. 282, eds McCormick D B, Suttie J W, and Wagner C, pp. 223-235, (Academic Press, San Diego).
3. Tezuka K, Sato T, Kamioka H, Nijweide P J, Tanaka K, Matsuo T, Ohya M, Kurihara N, Hakeda Y, and Kumegawa M (1992) Identification of osteopontin in isolated rabbit osteoclasts. Biochem. Biophys. Res. Commun. 186: 911-917.
4. Jimi E, Nakamura I, Amano H, Taguchi Y, Turukai T, Tamura N, Takahashi N, and Suda T (1996) Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137: 2187-2190.
5. Wesolowski G, Duong L T, Lakkakorpi P T, Nagy R M, Tezuka K, Tanaka H, Rodan G A, and Rodan S B (1995) Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp. Cell Res. 219: 679-686.
6. Hynes R O (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25.
7. Clark E A and Brugge J S (1995) Integrins and signal transduction pathways: the road taken. Science 268: 233-239.
8. 3 integrins 'vitronectin receptor'. Int. J. Biochem. Cell Biol. 29: 721-725.
9. Horton M A and Rodan G A (1996) Integrins as therapeutic targets in bone disease. In: Adhesion Receptors as Therapeutic Targets, ed. Horton M A, pp. 223-245, (CRC Press Inc., Boca Raton).
10. Chambers T J, Fuller K, Darby J A, Pringle J A S, and Horton M A (1986) Monoclonal antibodies against osteoclasts inhibit bone resorption in vivo. Bone Miner. 1: 127-135.
11. Davies J, Warwick J, Totty N, Philp R, Helfrich M, and Horton M (1989) The osteoclast's functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J. Cell Biol. 109: 1817-1826.
12. Clove J, Dodds R A, and Gowen M (1992) Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J. Cell Sci. 103: 267-271.
13. Sato M, Sardana M K, Grasser W A, Garsky V M, Murray J M, and Gould R J (1990) Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111: 1713-1723.
14. Horton M A, Taylor M L, Arnett T R, and Helfrich M H (1991 ) Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp. Cell Res. 195: 368-375.
15. Fisher J E, Caulfield M P, Sato M, Quartuccio H A, Gould R H, Garsky V M, Rodan G A, and Rosenblatt M (1993) Inhibition of osteoclastic bone resorption in vivo by echistatin, an 'arginul-glycyl-aspartyl' (RGD)-containing protein. Endocrinology 132: 1411-1413.
16. Crippes B A, Engleman V W, Settle S L, Delarco J, Ornberg R L, Helfrich M H, Horton M A, and Nickols G A (1996) Antibody to beta(3) integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat. Endocrinology 137: 918-924.
17. Masarachia P, Yamamoto M, Leu C-T, Rodan G, and Duong L T (1998) Histomorphometric evidence for echistatin inhibition of bone resorption in mice with secondary hyperparathyroidism. Endocrinology 139: 1401-1410.
18. 3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J. Clin. Invest. 99: 2284-2292.
19. Yamamoto M, Fisher J E, Gentile M, Seedor J G, Leu C-T, Rodan S B, and Rodan G A (1998) The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology 139: 1411-1419.
20. 3 integrins are osteosclerotic because of dysfunctional osteoclasts. J. Clin. Invest. 105: 433-440.
21. Nakamura I, Tanaka H, Rodan G A, and Duong L T (1998) Echistatin inhibits the migration of murine prefusion osteoclasts and the formation of multinucleated osteoclast-like cells. Endocrinology 139: 5182-5193.
22. 3 integrin in osteoclast migration and formation of the sealing zone. J. Cell Sci. 112: 3985-3993.
23. Reinholt F P, Hultenby K, Oldberg A, and Heinegard D (1990) Osteopontin - a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 87: 4473-4475.
24. Hultenby K, Reinholt F P, and Heinegard D (1993) Distribution of integrin subunits on rat metaphyseal osteoclasts and osteoblasts. Eur. J. Cell Biol. 62: 86-93.
25. 3 is present in the clear zone and contributes to cellular polarization. Cell Tissue Res. 286: 507-515.
26. Lakkakorpi P T, Horton M A, Helfrich M H, Karhukorpi E-K, and Väänänen H K (1991) Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J. Cell Biol. 115: 1179-1186.
27. 3 in osteoclasts: a study using confocal laser scanning microscopy. J. Cell Sci. 104: 663-670.
28. Thomas S M and Brugge J S (1997) Cellular functions regulated by Src family kinases. Ann. Rev. Cell Dev. Biol. 13: 513-609.
29. Soriano P, Montgomery C, Geske R, and Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
30. c-src in association with intracellular membranes. J. Cell Biol. 119: 1003-1013.
31. c-src, preferentially on ruffled border membranes. FEBS Lett. 313: 85-89.
32. c-src expression for osteoclasts to form ruffled border and resorb bone in mice. J. Clin. Invest. 90: 1622-1627.
33. Lowe C, Yoneda T, Boyce B F, Chen H, and Mundy G R (1993) Osteopetrosis in c-src-defident mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. USA 90: 4485-4489.
34. Schwartzberg P L, Xing L, Hoffmann O, Lowell C A, Garrett L, Boyce B F, and Vermas H E (1997) Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/-mutant mice. Genes Dev. 11: 2835-2844.
35. Xing L, Venegas A M, Chen A, Garrett-Beal L, Boyce B F, Vermas H E, and Schwartzberg P L (2001) Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival. Genes Dev. 15: 241-253.
36. Miyazaki T, Katagiri H, Kanegase Y, Takayanagi H, Sawada Y, Yamamoto A, Pando M P, Asano T, Verma I M, Oda H, Nakamura K, and Tanaka S (2000) Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J. Cell Biol. 148: 333-342.
37. Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy J B, and Baron R (1996) c-Cbl is downstream of c-Src in a signaling pathway necessary for bone resorption. Nature 383: 528-531.
38. 3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152: 181-195.
39. Joazeiro C A P, Wing S S, Huang H-K, Leverson J D, Hunter T, and Liu Y-C (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependnet ubiquitin-protein ligase. Science 286: 309-312.
40. Lee P S W, Wang Y, Dominguez M G, Yeung Y-G, Murphy M A, Bowtell D D L, and Stanley E R (1999) The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J. 18: 3616-3628.
41. Yokouchi M, Kondo T, Sanjay A, Houghton A, Yoshimura A, Komiya S, Zhang H, and Baron R (2001) Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J. Biol. Chem. 276: 35185-35193.
42. Murphy M A, Schnall R G, Venter D J, Barnett L, Bertoncello I, Thien C B F, Langton W Y, and Bowtell D D (1998) Tissue hyperplasia and enhanced T-cell signaling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell Biol. 18: 4872-4882.
43. 3 integrin, and associated with SRC kinase. J. Clin. Invest. 102: 881-892.
44. Schlaepfer D D and Hunter T (1998) Integrin signalling and tyrosine phosphorylation: just the FAKs. Trends Cell Biol. 8: 151-157.
45. FAK, in osteoclastic bone resorption. J. Cell Biochem. 58: 424-435.
46. Berry V, Rathod H, Pulman L B, and Datta H K (1994) Immunofluorescent evidence for the abundance of focal adhesion kinase in the human and avian osteoclasts and its down regulation by calcitonin. J. Endocrinol. 141: R11-R15.
47. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, and Hirai H (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13: 3748-3756.
48. Cas is involved in actin organization in osteoclasts. J. Biol. Chem. 273: 11144-11149.
49. Cas in osteoclasts and their co-localization in the sealing zone. J. Biol. Chem. 274: 4900-4907.
50. 3 integrin-and M-CSF-mediated signals in osteoclasts: the involvement of phospholipase-Cγ. J. Cell Biol. 152: 361-373.
51. Inoue J, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, and Yamamoto T (2000) Tumor necrosis factor receptor-associated factor (TRAF) family: adaptor proteins that mediate cytokine signaling. Exp. Cell Res. 254: 14-24.
52. Lomaga M A, Yeh W-C, Sarosi I, Duncan G S, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger J M, Paige C J, Lacey D, Dunstan C R, Boyle W J, Goeddek D V and Mak T W (1999) TRAF6 deficiency results in osteopetrosis and defective interlerkin-1, CD40, and LPS signaling. Genes Dev. 13: 1015-1024.
53. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, and Inoue J (1999) Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4: 353-362.
54. Nakamura I, Kadono Y, Takayanagi H, Jimi E, Miyazaki T, Oda H, Nakamura K, Tanaka S, Rodan G A, and Duong L T (2002 ) Interleukin-1 regulates cytoskeletal organization in osteoclasts via TRAF6/c-Src complex. J. Immunol. 168: 5103-5109.
55. Wong B R, Besser D, Kim N, Arron J R, Vologodskaia M, Hanafusa H, and Choi Y (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 4: 1041-1049.